Metabolically healthy obesity and incident chronic kidney disease: The role of systemic inflammation in a prospective study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28160438.
- Also identified by DOI 10.1002/oby.21768.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the association between the metabolically healthy obesity (MHO) phenotype and incident chronic kidney disease (CKD) in a Chinese population and whether systemic inflammation affects this association. A cohort study was performed with 2,491 Chinese adults. Body mass index ≥ 25.0 kg/m<sup>2</sup> was defined as obesity. CKD was defined as estimated glomerular filtration rate < 60 mL/min per 1.73 m<sup>2</sup> or urinary albumin-to-creatinine ratio ≥ 30 mg/g. High-sensitivity C-reactive protein (hsCRP) was used as a surrogate marker of systemic inflammation. Over a median follow-up period of 3.9 years, 243 of 2,491 participants developed incident CKD (9.8%). Compared with metabolically healthy nonobesity (MHNO), MHO was associated with incident CKD (odds ratio [OR] = 1.65, 95% confidence interval [CI] 1.01-2.69), but not after adjustment for hsCRP. The MHO/hsCRP ≥ 0.20 mg/L group, but not the MHO/hsCRP < 0.20 mg/L group, had an increased OR for incident CKD (OR = 2.66, 95% CI 1.37-5.14), with the MHNO/hsCRP < 0.20 mg/L group as the reference. MHO was significantly associated with incident CKD, and the level of systemic inflammation partially explained this association.
Medical subject headings
- Inflammation
- Obesity, Metabolically Benign
- Renal Insufficiency, Chronic